Business Context and Reporting Period
This Form 8-K filing by Perrigo Company plc, dated October 2, 2018, reports significant changes in executive leadership. The filing details the resignation of the former CEO and the immediate appointment of a successor, along with updates to the company's executive severance plan.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
- New CEO Base Salary: $1,200,000 annually.
- New CEO Target Bonus: 125% of base salary (minimum 50% payable if metrics are met).
- New CEO Sign-On Cash Bonus: $950,000.
- New CEO Sign-On Stock Options: Grant date fair value of $2,500,000.
- New CEO Annual Equity Grant (2019+): Grant date fair value of $7,750,000.
Material Changes
The primary material change is the departure of Uwe Roehrhoff as President, CEO, and Board member, effective October 8, 2018. He is entitled to benefits for termination without cause under his May 2018 employment agreement. Concurrently, Murray S. Kessler was appointed President, CEO, and Board member effective October 8, 2018.
Additionally, the Board extended the "Transition Period" for the Executive Severance Plan from January 15, 2019, to January 15, 2020. This extension ensures that specific severance protections for executive officers remain in effect for a longer duration following the leadership transition.
Outlook, Risks, and Contingencies
Management Commentary: The filing outlines the extensive background of the new CEO, Murray S. Kessler, highlighting his prior leadership roles at Lorillard Tobacco Company and Altria, Inc.
Compensation Contingencies: Mr. Kessler's employment agreement includes significant severance protections. In the event of termination without cause or resignation for good reason:
- Standard Termination: 1.5x sum of base salary and target bonus, plus 18 months of healthcare coverage.
- Change in Control Termination: 2x sum of base salary and target bonus, plus 6 months of additional healthcare coverage and full vesting of equity awards.
Risks: The agreement includes a 24-month post-termination non-compete and non-solicitation covenant.
Investor Verification Checklist
- Verify the specific terms of Uwe Roehrhoff's severance package referenced in the May 8, 2018 Form 10-Q.
- Review the full text of Exhibit 10.1 (Employment Agreement) for detailed performance metrics tied to Mr. Kessler's bonus and equity grants.
- Confirm the impact of the extended Transition Period on the total potential liability for executive severance payments.
- Assess the market reaction to the leadership change and the new CEO's background in consumer packaged goods and tobacco.